| Literature DB >> 23122295 |
Xu Shutu1, Zhang Dalong, Cai Ye, Zhou Yi, Trushar Shah, Farhan Ali, Li Qing, Li Zhigang, Wang Weidong, Li Jiansheng, Yang Xiaohong, Yan Jianbing.
Abstract
BACKGROUND: Tocopherols, which are vitamin E compounds, play an important role in maintaining human health. Compared with other staple foods, maize grains contain high level of tocopherols.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23122295 PMCID: PMC3502391 DOI: 10.1186/1471-2229-12-201
Source DB: PubMed Journal: BMC Plant Biol ISSN: 1471-2229 Impact factor: 4.215
Figure 1Vitamin E synthesis pathway. The three tocopherol compounds measured in this study are in red. Key enzymes in the pathway are labeled in bold type and the blue bold type indicates enzymes used for co-localization analysis. HPPD: 4-hydoxyphenyl-pyruvate dioxygenase; DXS: 1-deoxy-D-xylulose-5-phophate synthase; DXR: 1-deoxy-D-xylulose-5-phosphate reductase; GGPS: geranylgeranyl diphosphate synthase; VTE1: tocopherol cyclase; VTE2: HPT, homogentisic acid phytyltransferase; VTE3: 2-methyl-6-phytyl-1, 4-benzoquinol methyltransferase; VTE4: tocopherol methyltransferase; VTE5: phytol kinase; HGGT: homogentisate geranylgeranyl transferase; PSY: phytoene synthase.
Means, range, and broad-sense heritability () for tocopherols related traits
| γT | 3.95 ± 0.15 | 11.27 ± 0.68 | 09BJF2:3 | 11.02 ± 0.42 | 1.96-45.81 | 0.73 | 22.46 ± 0.76 | 2.70-66.28 | 0.81 | |
| | - | 10.37 | 33.40 | 09HNF2:4 | 10.96 ± 0.56 | 0.71-43.27 | | 22.32 ± 0.95 | 1.35-54.78 | |
| | - | - | - | 10HBF2:4 | 5.65 ± 0.22 | 1.42-17.95 | | 12.12 ± 0.62 | 1.30-38.23 | |
| αT | 5.13 ± 0.29 | 2.98 ± 0.21 | 09BJF2:3 | 8.24 ± 0.21 | 2.39-18.22 | 0.77 | 6.63 ± 0.22 | 0.67-23.73 | 0.59 | |
| | - | 14.95 | 5.57 | 09HNF2:4 | 10.11 ± 0.27 | 1.88-19.93 | | 6.66 ± 0.26 | 0.11-16.56 | |
| | - | - | - | 10HBF2:4 | 12.11 ± 0.3 | 3.71-25.14 | | 8.08 ± 0.35 | 0.93-34.10 | |
| TT | 9.18 ± 0.43 | 18.09 ± 1.06 | 09BJF2:3 | 19.24 ± 0.52 | 5.47-60.78 | 0.75 | 29.32 ± 0.78 | 7.30-74.58 | 0.79 | |
| | - | 25.32 | 38.97 | 09HNF2:4 | 21.07 ± 0.68 | 4.11-60.43 | | 29.16 ± 0.92 | 7.77-60.80 | |
| | - | - | - | 10HBF2:4 | 17.75 ± 0.44 | 5.26-33.87 | | 20.97 ± 0.72 | 3.65-51.53 | |
| α/γ | 0.60 ± 0.01 | 0.09 ± 0.01 | 09BJF2:3 | 0.94 ± 0.04 | 0.18-4.02 | 0.70 | 0.41 ± 0.02 | 0.02-2.70 | 0.68 | |
| | - | 1.44 | 0.17 | 09HNF2:4 | 1.41 ± 0.08 | 0.07-5.83 | | 0.63 ± 0.07 | 0.01-5.53 | |
| - | - | - | 10HBF2:4 | 2.61 ± 0.08 | 0.19-6.30 | 1.09 ± 0.08 | 0.05-5.31 | |||
a Average of three repeats tocopherols contents of the three parents in 2009 Beijing; b Broad-sense heritability of the tocopherols in the two populations; Note: The unit for γT, αT, and TT is μg/g, the max contents for each trait were bold type.
Marker characteristics by chromosome for the two linkage maps and the consensus map
| K22/CI7 | Number of markers | 55 | 39 | 48 | 45 | 55 | 45 | 37 | 44 | 36 | 25 | 429 |
| | Length(cM) | 202.3 | 132 | 154.1 | 144.9 | 194.4 | 138.6 | 105.5 | 135.7 | 104.6 | 77.2 | 1389.3 |
| | Average interval(cM) | 3.75 | 3.47 | 3.28 | 3.29 | 3.6 | 3.15 | 2.93 | 3.16 | 2.99 | 3.22 | 3.25 |
| K22/Dan340 | Number of markers | 52 | 22 | 39 | 20 | 30 | 41 | 30 | 46 | 31 | 33 | 344 |
| | Length (cM) | 249.7 | 170.7 | 162.8 | 137.7 | 154.5 | 140.2 | 143.2 | 166.5 | 130.7 | 111.5 | 1567.5 |
| | Average of interval | 4.9 | 8.13 | 4.28 | 7.25 | 5.33 | 3.51 | 4.94 | 3.7 | 4.36 | 3.48 | 4.57 |
| Commonb | Number of markers | 17 | 10 | 19 | 13 | 15 | 23 | 10 | 18 | 19 | 10 | 154 |
| Consensusc | Number of markers | 90 | 51 | 68 | 52 | 70 | 63 | 57 | 72 | 48 | 48 | 619 |
| | Length(cM) (cM) | 250.8 | 168 | 166.1 | 149 | 211.4 | 156.7 | 139.2 | 166.3 | 129.3 | 112.4 | 1649.03 |
| Average interval(cM) | 2.82 | 3.36 | 2.48 | 2.92 | 3.06 | 2.53 | 2.49 | 2.34 | 2.75 | 2.39 | 2.67 |
a entire linkage; b these markers exist in the two linkage maps; c the linkage map through integrating the two linkage maps into one map with the same markers.
QTLs for tocopherols in K22/CI7 population and related candidate genes
| γT | 09BJF2:3 | 2 | 25.91 | PZB00901.3-PZA03228.4 | 24.02-54.47 | 9.4-20.1 | 4.33 | −1.84 | −0.18 | 5.99 | | |
| | | 5 | 67.6 | PZA01327.1-PHM16854.3 | 62.04-77.24 | 15.1-35.3 | 11.84 | −3.9 | 0.58 | 17.61 | | |
| | | 5 | 183.2 | PHM3612.19-PHM13639.13 | 196.03-207.23 | 213.3-215.8 | 3.98 | 1.91 | −2.53 | 5.16 | | |
| | | 7 | 43.5 | PZA03149.4-PZA02643.1 | 48.86-62.83 | 108.8-134.1 | 6.12 | 2.85 | 0.37 | 8.83 | | |
| | 09HNF2:4 | 5 | 57.1 | PZA01371.1-PZA01327.1 | 43.04-62.04 | 8.3-15.1 | 4.97 | −2.81 | −0.68 | 11.01 | | |
| | | 5 | 93.5 | PZA00067.10-PZA00148.3 | 109.1-115.8 | 145.9-164.7 | 10.18 | −2.56 | −2.95 | 17.33 | | |
| | 10HBF2:4 | 5 | 67.6 | PZA01327.1-PHM16854.3 | 62.04-77.24 | 15.1-35.3 | 15.82 | −2.66 | 0.67 | 25.02 | | |
| | | 5 | 159.7 | PZA03161.1-PZA00545.26 | 144.6-177.68 | 186.4-207.7 | 5.53 | 1.12 | 0.31 | 7.75 | ||
| | | 6 | 6.81 | PHM15961.13-PZA03069.8 | 7.0-25.9 | 9.5-83.0 | 3.82 | −1.22 | 0.21 | 5.32 | | |
| αT | 09BJF2:3 | 1 | 75.4 | PHM2130.29-PHM1950.71 | 97.59-104.09 | 55.5-67.8 | 3.97 | −1.05 | 0.79 | 3.88 | | |
| | | 5 | 59.1 | PZA01327.1-PZB00869.4 | 62.04-74.57 | 15.1-33.1 | 5.3 | −1.18 | 0.23 | 6.19 | | |
| | | 5 | 150.8 | PZA00352.23-PZA02060.1 | 152.75-166.18 | 191.6-203.2 | 24 | −2.23 | −0.08 | 29.63 | ||
| | | 6 | 77.6 | PZA02262.3-PZB01308.2 | 87.7-95.2 | 134.9-144.6 | 4.66 | −0.79 | −0.29 | 4.66 | | |
| | 09HNF2:4 | 5 | 67.6 | PZA03226.3-PZA02207.1 | 67.14-79.77 | 20.2-49.9 | 4.13 | −1.57 | 0.11 | 6.11 | | |
| | | 5 | 150.8 | PZA00352.23-PZA02060.1 | 152.75-166.18 | 191.6-203.2 | 12.26 | −2.49 | 0.35 | 20.06 | ||
| | 10HBF2:4 | 1 | 66.1 | PZA00081.18-PZA03189.4 | 85.05-101.69 | 45.5-64.2 | 4.11 | −1.04 | −0.39 | 5.48 | | |
| | | 5 | 69.1 | PZA01327.1-PHM16854.3 | 62.04-77.24 | 15.1-35.3 | 14.64 | −2.73 | −0.16 | 18.17 | | |
| | | 5 | 149.5 | PZA00352.23-PZA02060.1 | 152.75-166.18 | 191.6-203.2 | 7.87 | −1.85 | −0.16 | 9.84 | ||
| TT | 09BJF2:3 | 1 | 68.1 | PZA00081.18-PHM1932.51 | 85.05-118.11 | 45.5-120 | 5.27 | −3.2 | 1.85 | 7.07 | | |
| | | 2 | 20.91 | PHM12952.13-PZB00901.4 | 12.9-25.32 | 4.9-9.4 | 4.09 | −1.64 | −1.05 | 5.99 | | |
| | | 5 | 54.1 | PZA01371.1-PZA01327.1 | 43.04-62.04 | 8.3-15.1 | 6.49 | −3.56 | 1.63 | 9.53 | | |
| | | 5 | 67.6 | PZA02113.1-PHM13675.17 | 72.97-90.34 | 31.0-67.5 | 12.49 | −4.6 | 0.48 | 16.87 | | |
| | | 5 | 150.8 | PZA00352.23-PZA02060.1 | 152.75-166.18 | 191.6-203.2 | 4.34 | −0.66 | −2.21 | 5.37 | ||
| | | 7 | 41.6 | PZA03149.4-PZA02643.1 | 48.86-62.83 | 108.8-134.1 | 5.31 | 2.61 | 1.11 | 6.9 | | |
| | 09HNF2:4 | 5 | 67.6 | PZA01327.1-PHM13675.17 | 62.04-90.34 | 15.1-67.5 | 14.89 | −7.05 | −0.89 | 26.51 | | |
| | 10HBF2:4 | 5 | 63.9 | PZA01327.1-PZA02207.1 | 62.04-79.77 | 15.1-49.9 | 11.24 | −5.35 | 0.93 | 15.47 | | |
| α/γ | 09BJF2:3 | 5 | 57.1 | PZA01327.1-PHM2769.43 | 62.04-83.27 | 15.1-58.5 | 6.79 | 0.28 | −0.08 | 9.17 | | |
| | | 6 | 59.2 | PZA01729.1-PZA02328.5 | 60.5-76.8 | 123.7-137.1 | 4.85 | −0.23 | 0.17 | 8.72 | | |
| | | 8 | 69.9 | PHM934.19-PZA02011.1 | 69.68-82.39 | 118.2-141.6 | 4.17 | −0.14 | −0.06 | 5.51 | | |
| | 09HNF2:4 | 5 | 66 | PZA03298.1-PHM16854.3 | 68.87-77.24 | 21.9-35.3 | 5.75 | 0.54 | 0.12 | 10.67 | | |
| | | 5 | 145.5 | PZA02751.1-PZA02513.1 | 151.05-165.68 | 190.7-203.3 | 9.08 | −0.51 | −0.28 | 18.37 | ||
| | 10HBF2:4 | 5 | 67.6 | PZA01327.1-PHM2769.43 | 62.04-83.27 | 15.1-58.5 | 10.52 | 0.74 | −0.25 | 12.65 | | |
| | | 5 | 159.7 | PZA00352.23-PZA02015.11 | 152.75-180.48 | 191.6-208.3 | 19.32 | −0.81 | −0.11 | 26.03 | ||
| 6 | 67.5 | PZA00473.5-PZA02262.3 | 60.4-87.7 | 124.1-134.9 | 6.05 | −0.56 | 0.3 | 8.29 |
a the QTL name which were defined only in our research; b the peak position with the highest LOD in the K22/CI7 map; c the physical distance from the website ( http://www.panzea.org/, B73_version 5a.60);d additive effect of the corresponding QTL, A; e dominance effect of the corresponding QTL, D; f the ratio of phenotypic variance can be explained by the QTL; * the physical position of these markers can be obtained from the website ( http://www.panzea.org/, B73_version 5a.60);
Note: the effect of the alleles assumes that the favorable allele came from K22.
QTLs for tocopherols in K22/Dan340 population and related candidate genes
| γT | 09BJF2:3 | 1 | 131 | PZA02750.3-PHM2187.34 | 119.28-127.7 | 102.6-157.1 | 4.52 | −3.88 | 1.29 | 3.03 | | |
| | | 1 | 167 | PZA02117.1-PHM4926.16 | 165.46-179.76 | 224.1-241.2 | 34.95 | −11.16 | 3.86 | 30.81 | | |
| | | 5 | 98.5 | PZA02751.1-PZA02068.1 | 151.05-169.78 | 190.7-205.3 | 15.05 | −6.08 | −0.15 | 12.06 | ||
| | | 8 | 81.6 | PZA02748.3-PZA02011.1 | 68.92-82.39 | 118.7-141.6 | 6.5 | 4.44 | −0.31 | 4.44 | | |
| | 09HNF2:4 | 1 | 167 | PHM3690.23-PZB01647.1 | 158.46-174.76 | 218.1-231.7 | 13.1 | −10.53 | 2.7 | 23.5 | | |
| | 10HBF2:4 | 1 | 49.8 | PZA00887.1-PZA00358.12 | 38.74-49.57 | 11.0-19.0 | 5.31 | −3.43 | 1.27 | 5.38 | | |
| | | 1 | 164 | PHM3690.23-kip1.3 | 158.46-190.8 | 218.1-256.5 | 24.31 | −6.25 | 0.47 | 32.63 | | |
| | | 2 | 67.7 | PZA03228.4-PHM10404.8 | 54.47-70.52 | 20.1-40.5 | 3.79 | −1.82 | −0.5 | 4.06 | | |
| | | 5 | 98.5 | PZA03161.1-PZA01265.1 | 144.6-163.15 | 186.5-202.0 | 14.35 | −4.45 | −1.39 | 18.2 | ||
| αT | 09BJF2:3 | 5 | 98.5 | PZA02751.1-PZA02068.1 | 151.05-169.78 | 190.7-205.3 | 21.88 | 3.58 | −0.17 | 52.75 | ||
| | | 8 | 75.4 | PZB00592.1-PHM4203.11 | 76.29-77.22 | 125.3-134.9 | 3.71 | −1.36 | 0.59 | 5.01 | | |
| | 09HNF2:4 | 5 | 96.5 | PZA02751.1-PZA02068.1 | 151.05-169.78 | 190.7-205.3 | 5.63 | 1.89 | 0.39 | 12.44 | ||
| | 10HBF2:4 | 1 | 169 | PHM3690.23-kip1.3 | 158.46-190.8 | 218.1-256.5 | 7.3 | −2.35 | 0.68 | 11.08 | | |
| | | 5 | 101 | PZA03161.1-PZA02068.1 | 144.6-169.78 | 186.5-205.3 | 21.76 | 3.93 | 0.87 | 39.09 | ||
| | | 10 | 30.1 | PZA01642.1-PZA00079.1 | 28.06-29.45 | 14.6-18.9 | 4.14 | 0.5 | −1.96 | 5.37 | | |
| TT | 09BJF2:3 | 1 | 106 | PZA02292.1-PZA01267.3 | 89.29-109.03 | 51.3-77.2 | 4.9 | −3.31 | −0.36 | 3.97 | | |
| | | 1 | 167 | PHM3690.23-PZB01647.1 | 158.46-174.76 | 218.1-231.7 | 42.07 | −12.34 | 3.42 | 50.67 | | |
| | | 5 | 85.3 | PZA01779.1-PZA00643.13 | 103.8-107.1 | 82.0-91.8 | 6.16 | −2.22 | −2.63 | 5.66 | ||
| | | 5 | 92.5 | PZA03161.1-PZA01265.1 | 144.6-163.15 | 186.5-202.0 | 7.54 | −3.29 | −1.53 | 6.22 | ||
| | 09HNF2:4 | 1 | 167 | PHM3690.23-PZB01647.1 | 158.46-174.76 | 218.1-231.7 | 13.42 | −10.49 | 2.9 | 25.28 | | |
| | 10HBF2:4 | 1 | 49.8 | PZA00887.1-PZA00358.12 | 38.74-49.57 | 11.0-19.0 | 4.72 | −4.14 | 1.52 | 5.62 | | |
| | | 1 | 164 | PHM3690.23-PZB01647.1 | 158.46-174.76 | 218.1-231.7 | 24.13 | −8.54 | 1.2 | 42.48 | | |
| | | 2 | 67.7 | PZA03228.4-PHM10404.8 | 54.47-70.52 | 20.1-40.5 | 3.74 | −2.95 | 0.69 | 4.71 | | |
| α/γ | 09BJF2:3 | 1 | 168 | PHM3690.23-PHM4926.16 | 158.46-179.76 | 218.1-241.2 | 24.2 | 0.3 | −0.15 | 26.67 | | |
| | | 5 | 101 | PZA02751.1-PZA02068.1 | 151.05-169.78 | 190.7-205.3 | 24.26 | 0.33 | −0.09 | 28.18 | ||
| | | 8 | 78.1 | PZB00592.1-LYCE.1 | 76.29-79.82 | 125.3-138.8 | 4.28 | −0.12 | −0.02 | 4.32 | | |
| | 09HNF2:4 | 1 | 167 | PHM3690.23-PZB01647.1 | 158.46-174.76 | 218.1-231.7 | 9.8 | 0.68 | −0.31 | 17.94 | | |
| | | 5 | 98.5 | PZA02751.1-PZA02068.1 | 151.05-169.78 | 190.7-205.3 | 5.47 | 0.59 | −0.31 | 10.56 | ||
| | 10HBF2:4 | 1 | 166 | PHM3690.23-PZB01647.1 | 158.46-174.76 | 218.1-231.7 | 3.61 | 0.46 | −0.15 | 4.71 | | |
| 5 | 98.5 | PZA03161.1-PZA02068.1 | 144.6-169.78 | 186.5-205.3 | 26.84 | 1.2 | −0.22 | 51 |
a the QTL name which were defined only in our research in K22/Dan340; b the peak position with the highest LOD in the K22/Dan340 map; c the physical distance from the website ( http://www.panzea.org/, B73_version 5a.60);d additive effect of the corresponding QTL, A; e dominance effect of the corresponding QTL, D; f the ratio of phenotypic variance can be explained by the QTL; * the physical position of these markers can be obtained from the website ( http://www.panzea.org/, B73_version 5a.60).
Note: the effect of the alleles assumes that the favorable allele came from K22.
Figure 2Distribution of major QTLs in the two maps (A), The two major QTLs on chromosome 5 in the POP-1 map (40–190 cM genetic distance); (B) The major QTL on chromosome 1 in the POP-2 map (130–200 cM genetic distance); (C) The major QTL on chromosome 5 in the POP-2 map (70 to 140 cM genetic distance). The symbol color of relates to the corresponding trait in each location beside the figure. Gray solid lines indicated the permutated threshold.
Figure 3Haplotype analyses and fine-mapping of in the early generation in POP-2 (A) Map position of in three environments. (B) Summary of genotype and phenotypic effects in the genomic regions that contains qd5-1. (C, D) The detailed haplotype analyses between types 1 and 3 (C) or types 2 and 3 (D) as in Figure 3B. The bars indicate the missing data. (E) The distribution of BACs (black lines) and candidate genes (red line indicates VTE4) in the genomic regions after fine mapping. The black lines mean each BAC and the red line represent the BAC that the candidate gene VTE4 located, all the BACs information is from web site ( http://www.maizesequence.org/ B73_version 5a.60),.
Comparison of QTLs detected in this study and in the study of Chander’s study
| 55.6-66.0Mb | αT, TT | 51.5-69.7Mb | αT, γT, TT | |
| 4.9-9.4Mb | TT | 2.6-5.5Mb | αT, γT, TT | |
| 8.2-34.6Mb | αT, γT, TT | 12.0-33.0Mb | γT, TT, α/γ | |
| 9.6-81.8Mb | γT | 77.7-95.0Mb | δT | |
| 103.4-128.4Mb | γT, TT | 85.0-134.0Mb | δT | |